David J. Marguglio, SVP and Chief Business Officer at Adamis Pharmaceuticals Corp (ADMP), sold 8,749 shares at $0.87 ($8K) on 2020-08-18, disclosed to the SEC on 2020-08-20.
Scheduled sale ($8k) by SVP and Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADMP | SELL | 2020-11-24 | $14K | — | Filing → |
| ADMP | SELL | 2020-11-20 | $3K | — | Filing → |
| ADMP | SELL | 2020-10-01 | $16K | — | Filing → |